About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

UNKNOWNPhase 4

Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment

Efficacies of Entecavir Add on Chronic Hepatitis B Patients With HBV DNA Load ≥1000 Copies/ml After 6 Months Treatment of Peginterferon Alpha 2a

NCT02368288•Beijing Ditan Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Chronic Hepatitis B

Interventions

entecavir

Locations

1

China

Locations (1)

Beijing Ditan hospital,Capital Medical University

Beijing, Beijing Municipality, China

Key Dates

Start Date

January 1, 2013

Primary Completion Date

December 1, 2016

Completion Date

December 1, 2016

Last Updated

August 18, 2016

Related Studies

RECRUITINGPhase 1

Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

NCT06671093

Chronic Hep BChronic Hepatitis b+2 more

RECRUITINGPhase 1

HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients

NCT06885710

Chronic Hepatitis b

RECRUITINGPhase 2

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

NCT06263959

Chronic Hepatitis B

RECRUITINGPhase 1/2

From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients

NCT06295328

Chronic Hepatitis b

Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b

NCT02883647

Chronic Hepatitis b

The Establishment of Korean Hepatitis B Patients Cohort

NCT04139850

Chronic Hepatitis B

View all related studies

Contacts

yao xie, MD

CONTACT

8610-84322489 xieyao00120184@sina.com

Sponsors

Lead Sponsor

Beijing Ditan Hospital

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 18, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions